
APDN to Showcase Linea™ DNA, Linea™ IVT Platforms at World Vaccine Congress
March 14th, 2024
APDN to Showcase Linea™ DNA, Linea™ IVT Platforms at World Vaccine Congress
March 14th, 2024
APDN Announces JDA to Integrate Linea™ IVT Platform into Kudo Biotechnology’s mRNA Manufacturing Workflow
December 14th, 2023
APDN Extends Application of Linea™ IVT Platform to saRNA (self-amplifying mRNA)
November 16th, 2023
Applied DNA Announces Availability and First Customer Shipment of New Linea™ IVT Evaluation Kit
August 29th, 2023
APDN Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Gen mRNA Production
August 23rd, 2023
APDN Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
July 18th, 2023
APDN Acquires Spindle Biotech, Launches LineaIVT Platform
July 13th, 2023
APDN Acquires Spindle Biotech, Launches LineaIVT™ Platform
July 13th, 2023
White Paper: Next Gen Medicines, The Therapeutic Potential of linearDNA Delivered via Lipid Nanoparticle
June 14th, 2023